Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD38 and CD138 expression in intrauterine adhesions with doxycycline after hysteroscopic adhesiolysis
ChiCTR1900027896Phase 4Not yet recruiting
- Sponsor
- Chongqing Health Center for Women and Children
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doxycycline in Intrauterine Adhesions (IUA) (3 arms), sponsored by Chongqing Health Center for Women and Children. Primary endpoints: CD38 expression and CD138 expression. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on ChiCTR1900027896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027896.